Glytec Advocacy for Advancing Diabetes Excellence
Supporting Hospitals and Health Systems Nationwide to Successfully Prepare
Glytec Recognizes CMS for its Ground-Breaking Advancement in Diabetes Excellence and proudly supports the recent mandate aimed at improving hyper- and hypoglycemia measures, which can be found here at CMS.gov FY 2025 IPPS Proposed Rule. This mandate is particularly beneficial for rural and underserved areas, addressing the unfair impact of diabetes on these communities. “We applaud CMS’s move to mandate hyper and hypoglycemia measures. This initiative significantly advances diabetes excellence in the United States, particularly benefiting rural and underserved areas, and we anticipate that State Medicaid and Commercial Health Plans will adopt similar measures,” said Patrick Cua, President and CEO at Glytec.
Highlighting our 18 years of experience, Glytec is the first and only FDA-cleared insulin management software in the market, managing patients across the continuum of care, from hospitalization to home. We are committed to providing comprehensive support to hospitals and communities, ensuring the successful implementation and continuous maintenance of diabetes management systems. Our solutions are designed to adapt to new drugs and scenarios, ensuring ongoing efficacy and safety. Nearly one out of two hospital patients require insulin management, highlighting the urgent need for effective diabetes care. The percentage of patients needing insulin is rising, making it imperative to start the implementation process now. Our solutions not only address these needs but also reduce health inequities, particularly in underserved populations.
As the only FDA-cleared insulin management solution, Glytec offers a unique combination of innovation and trust. Our advanced Command Center and ongoing conversations at the government level set us apart from unproven alternatives. The complexity of self-built solutions contrasts with our comprehensive, continually updated system, reducing the maintenance burden on hospitals. Glytec is offering hospitals and healthcare systems across the country the expertise and resources needed to manage the CMS mandate process effectively. They can request a detailed checklist of requirements and a comprehensive implementation plan, with experts ready to assist at every step. Given that most hospitals are currently in their budgeting process, now is the prime time to start discussions to meet the 2026 go-live date. The urgency to begin cannot be overstated.
